Quarterly report pursuant to Section 13 or 15(d)

Schedule of Stock Options Granted and Outstanding (Details)

v3.22.2.2
Schedule of Stock Options Granted and Outstanding (Details)
9 Months Ended
Sep. 30, 2022
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Stock option, beginning balance | shares 1,137,479
Weighted average exercise price, beginning balance | $ / shares $ 5.18
Shares, options granted | shares 367,500
Weighted average exercise price, options granted | $ / shares $ 1.63
Stock option, ending balance | shares 1,504,979
Weighted average exercise price, ending balance | $ / shares $ 4.32
Stock option, exercisable | shares 1,208,015
Weighted average exercise price, exercisable | $ / shares $ 4.48